Skip to content

Ayurvedic multi-dimentional management of Chronic Kidney Disease

Clinical study on the deceleration of disease progression of chronic kidney disease by Ayurvedic management - A quasi-experimental study - NIL

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099713
Enrollment
130
Registered
2025-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N181- Chronic kidney disease, stage 1 Health Condition 2: N182- Chronic kidney disease, stage 2 (mild) Health Condition 3: N183- Chronic kidney disease, stage 3 (moderate)

Interventions

None listed

Sponsors

Central Council of Research in Ayurvedic Science
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i. Participants of both genders aged 18 65 years ii. Participants who are non-dialysis dependent known patients of CKD (up to stage 4) with or without diagnosed as DM and on medication, diagnosed as hypertensive and on medication.

Exclusion criteria

Exclusion criteria: 1. Patients with cystic and tubulointerstitial nephropathy, Left ventricular hypertrophy, and dilated cardiomyopathy conditions associated with hyporeninemic hypoaldosteronism, and renal diseases that preferentially affect the distal nephron, such as obstructive uropathy and sickle cell nephropathy. 2. Patients diagnosed as having later stages of CKD with prolonged bleeding time, decreased activity of platelet factor III, abnormal platelet aggregation and adhesiveness, and impaired prothrombin consumption, clinically increased tendency to bleeding and bruising, prolonged bleeding from surgical incisions, menorrhagia, and GI bleeding. 3. There are many exclusion criteria but the web site doent proceed if I write all at here.

Design outcomes

Primary

MeasureTime frame
Changes in eGFRTimepoint: Before 6 months of ayurveda treatment (TP: -6), On the day of starting ayurveda treatment (TP: 0) After the 6 months of Ayurveda treatement (TP: +6).

Secondary

MeasureTime frame
Changes in signs and symptomsTimepoint: Before and after the 6 months of administration of ayurveda treatment;Changes in laboratory investigations i.e. CBC, CRP, renal function tests, homocystin C, UACR, electrolytes and calcium,Timepoint: Before and after the 6 months of administration of ayurveda medicine.;Changes in USG of abdomenTimepoint: Before and after the 6 months of administration of ayurveda treatment.;Changes in Quality of life of the patients by using KDQoLTimepoint: Before and after the 6 months of administration of ayurveda treatment.;Find out safety by observing changes in Liver Function Tests and AE and SAE.Timepoint: Before and after the 6 months of administration of ayurveda treatment.

Countries

India

Contacts

Public ContactPATEL MANISHKUMAR VADILAL

JS Ayurveda Mahavidyalaya and P D Patel Ayurveda Hospital

manishayu97@yahoo.com9979589865

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026